Key facts
- Notable investors include Continuity Biosciences, Hyperspace Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for PinPrint
- ·The full record, as it builds
Funding rounds
No funding rounds for PinPrint are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PinPrint
Developer of microneedle patches designed for intradermal delivery of vaccines and active agents. The company's technology combines 3D printing with advanced drug delivery, enabling healthcare providers and patients with a new standard of precision, personalization, and comfort in both therapeutic and cosmetic applications.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2023
- Website
- pinprint.com/
- Ownership
- Privately Held (backing)
PinPrint doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PinPrint shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PinPrint in its N-PORT filings yet. We sweep new filings monthly.